<DOC>
	<DOCNO>NCT02737592</DOCNO>
	<brief_summary>To evaluate safety personal lubricant use least four time weekly two week ( include least twice weekly sexual intercourse subject monogamous male partner ) , population consist healthy female .</brief_summary>
	<brief_title>A Clinical Study Evaluate Safety Personal Lubricant Healthy Female Subjects</brief_title>
	<detailed_description />
	<mesh_term>Erythema</mesh_term>
	<criteria>participation similar study 2weeks prior may postmenopausal hysterectomy sexually active , child bear potential , subject use adequate nonbarrier method birth control free vaginal disorder sexually active monogamous , heterosexual relationship , whose male partner willing able give inform consent agree engage sexual intercourse least twice week twoweek study sexually active personal lubricant user agree replace usual personal lubricant investigational product start regardless cycle agree use provide investigational product least four time weekly two week study period exhibit clinically significant evidence vulvar vaginal irritation , determine study doctor , report sensory irritation baseline exam willing refrain introduce new vaginal product , use vaginal medication local contraceptive study agree refrain douche use medication , powder , lotion personal care product vulvar perianal area willing use urine pregnancy test provide baseline third visit standard medical history form file sign informed consent complete HIPAA dependable able follow direction outline receives score 0 0.5 erythema edema ; 0 sensorial irritation ( burning , sting , itch dryness ) first examination . pregnant , nurse plan pregnancy currently use use within two week prior study initiation , systemic topical corticosteroid , vasoconstrictor , antibiotic , antiinflammatories antihistamines know allergy vaginal cosmetic product report history recurrent bladder , vaginal infection incontinence exhibit report gynecologic abnormality vaginitis within 60 day prior study initiation us vaginal ring , diaphram cervical/vault cap , condom , condom spermicide mean contraception participate study involve vaginal area investigational systemic drug study within two week study initiation receives score high 0/5 erythema , edema &gt; 0 burning , sting , itch , first examination show sign mucosal irregularity</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>